期刊文献+
共找到188篇文章
< 1 2 10 >
每页显示 20 50 100
Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations
1
作者 Fei Di Tongyan Chen +4 位作者 Hongli Li Jizong Zhao Shuo Wang Yuanli Zhao Dong Zhang 《Neural Regeneration Research》 SCIE CAS CSCD 2012年第19期1513-1519,共7页
In this study, we determined the expression levels of matrix metalloproteinase-2 and -9 and matrix metalloproteinase tissue inhibitor-1 and -2 in brain tissues and blood plasma of patients undergoing surgery for cereb... In this study, we determined the expression levels of matrix metalloproteinase-2 and -9 and matrix metalloproteinase tissue inhibitor-1 and -2 in brain tissues and blood plasma of patients undergoing surgery for cerebellar arteriovenous malformations or primary epilepsy (control group). Immunohistochemistry and enzyme-linked immunosorbent assay revealed that the expression of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 was significantly higher in patients with cerebellar arteriovenous malformations than in patients with primary epilepsy. The ratio of matrix metalloproteinase-9 to matrix metalloproteinase tissue inhibitor-1 was significantly higher in patients with hemorrhagic cerebellar arteriovenous malformations compared with those with non-hemorrhagic malformations. Matrix metalloproteinase-2 and matrix metalloproteinase tissue inhibitor-2 levels were not significantly changed. These findings indicate that an imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-I, resulting in a relative overabundance of matrix metalloproteinase-9, might be the underlying mechanism of hemorrhage of cerebellar arteriovenous malformations. 展开更多
关键词 cerebellar arteriovenous malformations HEMORRHAGE matrix metalloproteinase-2 matrixmetalloproteinase-9 tissue matrix metalloproteinase inhibitor-1 tissue matrix metalloproteinaseinhibitor-2 IMMUNOHISTOCHEMISTRY enzyme-linked immunosorbent assay neural regeneration
下载PDF
Serum Matrix Metalloproteinase 3 and Tissue Inhibitor Metalloproteinase 1 in Vascular Dementia: A Comparative Study
2
作者 Mohammed Zain Abdelwadoud Hussein 《Advances in Aging Research》 2015年第5期154-160,共7页
Aim: To compare serum level of matrix metalloproteinase 3 (MMP3) and tissue inhibitor metallo-proteinase 1 (TIMP1) in vascular dementia patients and healthy control subjects. Methods: A case control study was carried ... Aim: To compare serum level of matrix metalloproteinase 3 (MMP3) and tissue inhibitor metallo-proteinase 1 (TIMP1) in vascular dementia patients and healthy control subjects. Methods: A case control study was carried out in Ain Shams University hospital, Cairo, Egypt. 32 cases with vascular dementia were collected and classified into 2 subgroups;vascular dementia of multiinfarct type (VDMI) 14 patients, and vascular dementia of subcortical type (VDSC) 18 subjects. 23 cases with normal cognitive functions were collected as control group. Cases were subjected to comprehensive geriatric assessment, neurological examination, neuropsychological testing and brain CT scan. Blood sample was collected to analyze serum level of matrix metalloproteinase 3 (MMP3) and tissue inhibitor metalloproteinase 1 (TIMP1). Results: Mean serum level of TIMP1 (20.85 × 103 picogram/ml) was significantly lower than mean serum level of TIMP1 in control group (27.69 × 103 picogram/ml) (p = 0.018). The same finding was also evident when comparing VDMI subgroup mean serum TIMP1 (18.71 × 103 pc/ml) to control group (p = 0.025). There was no significant difference between mean serum MMP3 levels in cases group (mean = 67.39 × 103) as compared to control group (mean = 61.65 × 103 pc/ml) (p = 0.519). Conclusion: Patients with VD particularly VDMI has lower serum level of TIMP1 as compared to control group. 展开更多
关键词 Multiinfarct DEMENTIA matrix metalloproteinasE 3 tissue INHIBITOR Me Talloproteinase 1 VASCULAR DEMENTIA VASCULAR DEMENTIA of SUBCORTICAL Type
下载PDF
乳腺癌组织中TIMP-3及DNMT1的表达与患者预后的相关性
3
作者 于娇 李汉杰 +3 位作者 陈鑫 王青 葛鹏 李刚 《现代肿瘤医学》 CAS 2024年第17期3248-3253,共6页
目的:分析研究乳腺癌患者中基质金属蛋白酶组织抑制因子3(TIMP-3)及DNA甲基转移酶1(DNMT1)的表达水平与患者临床预后的相关性。方法:收集58例临床资料完整的乳腺癌手术切除标本,采用免疫组化SP法检测癌组织及相应癌旁组织中TIMP-3、DNMT... 目的:分析研究乳腺癌患者中基质金属蛋白酶组织抑制因子3(TIMP-3)及DNA甲基转移酶1(DNMT1)的表达水平与患者临床预后的相关性。方法:收集58例临床资料完整的乳腺癌手术切除标本,采用免疫组化SP法检测癌组织及相应癌旁组织中TIMP-3、DNMT1、ER、PR、HER-2、p53、Ki-67的表达,将TIMP-3、DNMT1表达水平与临床病理参数及随访生存状况进行相关性分析,所有入组患者均进行随访5年以上。结果:我们发现,在乳腺癌组织中,TIMP-3呈低表达,DNMT1呈高表达,TIMP-3及DNMT1的表达呈负相关;TIMP-3表达水平与Ki-67呈负相关,DNMT1表达水平与Ki-67呈正相关,与其他临床病理参数未见相关性。Cox风险比例模型分析显示只有临床分期和DNMT1表达水平是影响总生存期(OS)和无病生存期(DFS)的独立风险因素。TIMP-3低表达组的5年OS和DFS均显著低于高表达组,DNMT1高表达组的5年OS和DFS均显著低于低表达组。结论:研究表明乳腺癌中TIMP-3及DNMT1表达水平与肿瘤细胞恶性表型及患者生存时间有关,可能成为判断乳腺癌预后的一项重要指标,并作为治疗计划制定的依据。 展开更多
关键词 乳腺癌 基质金属蛋白酶组织抑制因子3 DNA甲基转移酶1 总生存期 无病生存期
下载PDF
电针对负透镜诱导型近视豚鼠视网膜中MMP-3和TIMP-3及Col3α1表达的影响
4
作者 刘一洁 郝琪 +2 位作者 卢秀珍 吴秋欣 毕宏生 《国际眼科杂志》 CAS 2024年第9期1373-1380,共8页
目的:探讨电针对负透镜诱导型近视豚鼠视网膜中基质金属蛋白酶(MMP)-3、金属蛋白酶组织抑制剂(TIMP)-3和III型胶原α1(Col3α1)表达的影响。方法:将80只豚鼠随机分为正常对照组、负透镜诱导型近视组、电针干预组和假穴组,每组20只。正... 目的:探讨电针对负透镜诱导型近视豚鼠视网膜中基质金属蛋白酶(MMP)-3、金属蛋白酶组织抑制剂(TIMP)-3和III型胶原α1(Col3α1)表达的影响。方法:将80只豚鼠随机分为正常对照组、负透镜诱导型近视组、电针干预组和假穴组,每组20只。正常对照组不做任何干预,负透镜诱导型近视组、电针干预组和假穴组,右眼均配戴-6.0 D透镜,左眼不戴镜。戴镜同时电针干预组在合谷穴与太阳穴给予电针刺激,假穴组豚鼠在假穴位进行干预。造模前,造模2、4 wk检影验光检测屈光度,A超检测眼轴长度,HE染色观察视网膜组织结构变化,定量聚合酶链反应(Q-PCR)和蛋白免疫印迹(WB)检测视网膜中MMP-3、TIMP-3、Col3α1 mRNA和蛋白表达的情况。结果:造模2、4 wk,负透镜诱导型近视组与正常对照组相比眼轴长度均明显增加(均P<0.05),屈光度均明显降低(均P<0.05);与负透镜诱导型近视组相比,电针干预组干预后眼轴长度均减少(均P<0.05),屈光度均增加(均P<0.05)。HE染色显示,正常对照组豚鼠视网膜组织各层分界明显,排列规则;负透镜诱导型近视组视网膜厚度、内外核层厚度及细胞数量减少,排列不规则;电针干预组视网膜整体结构较为完善,排列较规则,组织各层形态结构未出现明显异常。Q-PCR和WB检测结果显示,负透镜诱导型近视组视网膜中MMP-3、TIMP-3和Col3α1 mRNA及蛋白表达均比正常对照组明显升高(均P<0.05);而电针干预组干预后视网膜中MMP-3、TIMP-3和Col3α1mRNA及蛋白表达均较负透镜诱导型近视组明显降低(均P<0.05)。结论:电针能够延缓负透镜诱导型近视豚鼠眼轴增长,下调负透镜诱导型近视豚鼠视网膜中的MMP-3、TIMP-3及Col3α1 mRNA及蛋白表达。 展开更多
关键词 负透镜诱导型近视 电针 基质金属蛋白酶-3(MMP-3) 金属蛋白酶组织抑制剂-3(TIMP-3) Ⅲ型胶原α1(Col3α1) 视网膜
下载PDF
Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitis 被引量:2
5
作者 Laura Mkitalo Maija Piekkala +7 位作者 Merja Ashorn Mikko Pakarinen Antti Koivusalo Riitta Karikoski Johanna Natunen Ulpu Saarialho-Kere Risto Rintala Kaija-Leena Kolho 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第30期4028-4036,共9页
AIM:To investigate matrix metalloproteinases(MMPs) and their tissue inhibitors(TIMPs) in pouch mucosa of pediatric onset ulcerative colitis(UC).METHODS:In this cross-sectional study,28 patients with pediatric onset UC... AIM:To investigate matrix metalloproteinases(MMPs) and their tissue inhibitors(TIMPs) in pouch mucosa of pediatric onset ulcerative colitis(UC).METHODS:In this cross-sectional study,28 patients with pediatric onset UC underwent ileal pouch biopsy 13 years(median) after proctocolectomy.Expression of MMPs-3,-7,-8,-9,-12 and-26 and TIMPs-1,-2 and-3 in samples was examined using immunohistochemichal methods,and another biopsy was used to evaluate the grade of histological inflammation.Two investigators independently graded the immunohistochemical specimens in a semiquantitative fashion,using a scale marking staining intensity as follows:0 = less than 20 positive cells;1 = 20-50 positive cells;2 = 50-200 positive cells;3 = over 20 positive cells.Fecal calprotectin and blood inflammatory markers [serum C-reactive protein(CRP) and erythrocyte sedimentation rate] were determined during a follow-up visit to examine correlations between these markers and the expression of MMPs and TIMPs.RESULTS:Of the 28 patients with pediatric onset UC,nine had not experienced pouchitis,whereas thirteen reported a single episode,and six had recurrent pouchitis(≥ 4 episodes).At the time of the study,six patients required metronidazole.In all of the others,the most recent episode of pouchitis had occurred over one month earlier,and none were on antibiotics.Only four samples depicted no sign of inflammation,and these were all from patients who had not had pouchitis.Two samples were too small to determine the grade of inflammation,but both had suffered pouchitis,the other recurrent.No sample depicted signs of colonic metaplasia.Most pouch samples showed expression of epithelial(e) and stromal(s) MMP-3(e,n = 22;s,n = 20),MMP-7(e,n = 28;s,n = 27),MMP-12(e,n = 20;s,n =24),TIMP-2(e,n = 23;s,n = 23) and MMP-3(e,n = 23;s,n = 28) but MMP-8(e,n = 0;s,n = 1),MMP-9(e,n = 0;s,n = 9) and MMP-26(e,n = 0;s,n = 3) and TIMP-1(n = 0,both) were lacking.In samples with low grade of inflammatory activity,the epithelial MMP-3 and MMP-7 expression was increased(r =-0.614 and r =-0.472,respectively,P < 0.05 in both).MMPs and TIMPs did not correlate with the markers of inflammation,fecal calprotectin,erythrocyte sedimentation rate,or CRP,with the exception of patients with low fecal calprotectin(< 100 μg/g) in whom a higher expression of epithelial MMP-7 was found no differences in MMPor TIMP-profiles were seen in patients with a history of pouchitis compared to ones with no such episodes.Anastomosis with either straight ileoanal anastomosis or ileoanal anastomosis with J-pouch did depict differences in MMP-or TIMP-expression.CONCLUSION:The expression of MMPs pediatric UC pouch in the long-term shares characteristics with inflammatory bowel disease,but inflammation cannot be classified as a reactivation of the disease. 展开更多
关键词 Children matrix metalloproteinase 3 tissue inhibitor of matrix metalloproteinase 3 matrix metalloproteinase 7 Pouchitis Ulcerative colitis
下载PDF
MATRIX METALLOPROTEINASE AND THEIR INHIBITORS: MOLECULAR ASPECTS OF THEIR ROLES IN THE TUMOR METASTASIS 被引量:4
6
作者 李克勤 李春海 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2000年第4期239-243,共5页
The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes, whose physiological functions include tissue remo-delling and embryogenesis. The importance of this group of proteins in the processes of tumor... The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes, whose physiological functions include tissue remo-delling and embryogenesis. The importance of this group of proteins in the processes of tumor invasion and metastasis is now widely acknowledged, and has led to the search for MMP inhibitors for use as anticancer treatments in a clinical setting. The review aims to introduce current research relating to MMPs as well as their native and synthetic inhibitor, with particular emphasis on the molecular aspects of their roles in tumor metastasis. 展开更多
关键词 matrix metalloproteinase tissue inhibitor of matrix metalloproteinase TUMOR gene regulation
下载PDF
阿尔茨海默病患者血清Ang、TIMP3水平与β-淀粉样蛋白沉积及认知功能的关系 被引量:3
7
作者 周慧敏 陈静 +2 位作者 王御林 欧诒丹 钟纯正 《国际检验医学杂志》 CAS 2023年第4期416-420,共5页
目的探讨阿尔茨海默病(AD)患者血清血管抑制素(Ang)、组织金属蛋白酶抑制剂3(TIMP3)水平与β-淀粉样蛋白(Aβ)沉积及认知功能的关系。方法将2020年1月至2022年5月于该院治疗的143例AD患者纳入研究作为AD组,另选取同期55例体检健康者作... 目的探讨阿尔茨海默病(AD)患者血清血管抑制素(Ang)、组织金属蛋白酶抑制剂3(TIMP3)水平与β-淀粉样蛋白(Aβ)沉积及认知功能的关系。方法将2020年1月至2022年5月于该院治疗的143例AD患者纳入研究作为AD组,另选取同期55例体检健康者作为对照组。采用酶联免疫吸附法检测血清Ang、TIMP3水平。采用Pearson/Spearman相关分析AD患者血清Ang、TIMP3水平与Aβ1-40、Aβ1-42、总Tau(t-Tau)、磷酸化Tau181(p-Tau181)水平和简易精神状态检查表(MMSE)评分的相关性,绘制受试者工作特征(ROC)曲线分析血清Ang、TIMP3水平对AD的诊断价值。结果AD组血清Ang、TIMP3水平均低于对照组,差异有统计学意义(P<0.05)。Pearson/Spearman相关分析显示:AD患者血清Ang、TIMP3水平与Aβ1-40水平(r=-0.446、-0.465,P<0.05)及MMSE评分(r=-0.558、-0.607,P<0.05)均呈负相关,与Aβ1-42水平呈正相关(r=0.443、0.437,P<0.05),与t-Tau、p-Tau181水平无明显的相关性(P>0.05)。ROC曲线分析显示,血清Ang、TIMP3水平单项及联合用于AD诊断的曲线下面积(AUC)分别为0.798、0.793、0.901,灵敏度分别为96.50%、67.13%、74.13%,特异度分别为56.36%、80.00%、90.91%。血清Ang、TIMP3水平联合用于AD诊断的AUC大于二者单项用于AD诊断(P<0.05)。结论血清Ang、TIMP3水平降低与AD患者认知功能下降和Aβ沉积有关,可作为AD诊断的辅助指标,而且血清Ang、TIMP3水平联合检测有助于提升对AD的诊断效能。 展开更多
关键词 阿尔茨海默病 血管生成 血管抑制素 组织金属蛋白酶抑制剂3 Β-淀粉样蛋白
下载PDF
TGF-β1/Smad3信号通路调控MMP-13/TIMP-1蛋白表达在糖尿病膀胱纤维化中的作用研究
8
作者 周海永 郁建迪 +3 位作者 闻华立 彭昆 颜俊锋 汪星 《浙江医学》 CAS 2023年第15期1598-1602,1620,共6页
目的探讨转化生长因子β1(TGF-β1)/细胞信号转导分子3(Smad3)信号通路调控基质金属蛋白酶13(MMP-13)/基质金属蛋白酶抑制剂1(TIMP-1)蛋白表达在糖尿病膀胱纤维化中的作用。方法将80只雄性Wistar大鼠按随机数字表法分为糖尿病组和正常... 目的探讨转化生长因子β1(TGF-β1)/细胞信号转导分子3(Smad3)信号通路调控基质金属蛋白酶13(MMP-13)/基质金属蛋白酶抑制剂1(TIMP-1)蛋白表达在糖尿病膀胱纤维化中的作用。方法将80只雄性Wistar大鼠按随机数字表法分为糖尿病组和正常对照组,每组40只;另取20只糖尿病大鼠按随机数字表法分为TGF-β1敲除组和Smad3敲除组,每组10只。采用链脲佐素65 mg/kg一次性给药法建立糖尿病模型;采用Cas9 gene targeting技术分别敲除TGF-β1或Smad3基因。采用HE或VG染色法观察糖尿病组与正常对照组大鼠膀胱组织病理学形态,Western blot法检测并比较糖尿病组与正常对照组、糖尿病组与TGF-β1敲除组、糖尿病组与Smad3敲除组大鼠膀胱平滑肌组织中相关信号通路因子蛋白表达水平,包括TGF-β1、Smad3、MMP-13、TIMP-1、Ⅰ型胶原蛋白(colⅠ)、Ⅲ型胶原蛋白(colⅢ)等。结果HE及VG染色结果显示,糖尿病组大鼠膀胱组织胶原纤维明显增多。糖尿病组大鼠膀胱平滑肌组织中TGF-β1、Smad3、MMP-13、TIMP-1蛋白表达水平均明显高于正常对照组,MMP-13、TIMP-1、colⅠ、colⅢ蛋白表达水平均明显高于TGF-β1敲除组、Smad3敲除组,差异均有统计学意义(均P<0.05)。结论MMP-13、TIMP-1在糖尿病膀胱纤维化中呈高表达。TGF-β1/Smad3信号通路通过调控MMP-13/TIMP-1蛋白表达参与糖尿病膀胱纤维化的发生、发展。 展开更多
关键词 糖尿病 膀胱 纤维化 基质金属蛋白酶13 基质金属蛋白酶抑制剂1 转化生长因子β1/细胞信号转导分子3信号通路
下载PDF
LncRNA MEG3调控microRNA-181b-5p/TIMP3对前列腺癌细胞侵袭、迁移的影响
9
作者 梁紫积 陈楚义 《现代泌尿外科杂志》 CAS 2023年第1期71-77,共7页
目的探究长链非编码RNA母系表达基因3(lncRNA MEG3)调控微小RNA-181b-5p(microRNA-1816-5P,简称miR-181b-5p)/组织金属蛋白酶抑制因子3(TIMP3)对前列腺癌细胞侵袭、迁移的影响。方法收集2019年12月—2021年12月本院所收治的20例前列腺... 目的探究长链非编码RNA母系表达基因3(lncRNA MEG3)调控微小RNA-181b-5p(microRNA-1816-5P,简称miR-181b-5p)/组织金属蛋白酶抑制因子3(TIMP3)对前列腺癌细胞侵袭、迁移的影响。方法收集2019年12月—2021年12月本院所收治的20例前列腺癌患者前列腺癌组织及其对应癌旁组织;实时荧光定量PCR(qRT-PCR)检测组织MEG3、miR-181b-5p表达;将前列腺癌细胞(PC3细胞)随机分为对照组(未处理)、pcDNA3.1-NC组(转染pcDNA3.1-NC)、pcDNA3.1-MEG3组(转染pcDNA3.1-MEG)、pcDNA3.1-MEG3+miR-NC组(pcDNA3.1-MEG3与miR-NC共转染)、pcDNA3.1-MEG3+miR-181b-5p mimic组(pcDNA3.1-MEG3与miR-181b-5p mimic共转染);qRT-PCR检测细胞MEG3、miR-181b-5p表达;MTT实验、Transwell实验、划痕实验分别检测PC3细胞活力、侵袭及迁移能力;Western blot检测PC3细胞TIMP3、基质金属蛋白酶(MMP)9、MMP2蛋白表达;双荧光素酶实验检测MEG3、miR-181b-5p、TIMP3的靶向关系。结果与癌旁组织的表达相比,MEG3在前列腺癌组织(0.37±0.05 vs.1.00±0.04)及细胞(0.31±0.06 vs.1.00±0.01)中表达显著降低(P<0.05);与对照组相比,pcDNA3.1-MEG3组miR-181b-5p表达(0.26±0.04 vs.1.00±0.02)、细胞存活率(53.60±5.22 vs.100.00±0.00)、侵袭细胞数(62.33±9.85 vs.162.34±21.30)、细胞迁移率(32.85±3.80 vs.75.22±5.96)、MMP9(0.61±0.08 vs.1.62±0.23)、MMP2(0.73±0.10 vs.1.20±0.16)表达显著降低,MEG3(2.31±0.36 vs.1.00±0.01)、TIMP3蛋白(1.32±0.24 vs.0.53±0.08)表达显著增加(P<0.05);miR-181b-5p过表达可逆转上述指标变化(P<0.05);miR-181b-5p与MEG3、TIMP3间均存在靶向关系。结论lncRNA MEG3过表达可通过抑制miR-181b-5p来促进TIMP3表达,从而抑制PC3细胞侵袭、迁移。 展开更多
关键词 母系表达基因3 微小RNA-181b-5p 组织金属蛋白酶抑制因子3 前列腺癌 侵袭 迁移
下载PDF
腹膜透析患者腹膜冲洗液MMPs/TIMPs、25(OH)D 3水平变化与腹膜透析相关性腹膜炎、腹膜纤维化的关系
10
作者 姜燕 臧秀娟 +2 位作者 郑峰 吴水 邵伟娟 《临床误诊误治》 CAS 2023年第1期95-100,共6页
目的探究腹膜透析(PD)患者腹膜冲洗液基质金属蛋白酶(MMPs)/金属蛋白酶组织抑制因子(TIMPs)、血25-羟基维生素D_(3)[25(OH)D_(3)]水平变化与腹膜透析相关性腹膜炎(PDAP)、腹膜纤维化的关系。方法收集2018年1月—2020年1月收治的58例PD... 目的探究腹膜透析(PD)患者腹膜冲洗液基质金属蛋白酶(MMPs)/金属蛋白酶组织抑制因子(TIMPs)、血25-羟基维生素D_(3)[25(OH)D_(3)]水平变化与腹膜透析相关性腹膜炎(PDAP)、腹膜纤维化的关系。方法收集2018年1月—2020年1月收治的58例PD为研究对象,根据是否发生PDAP分为PDAP组和无PDAP组,根据是否出现腹膜纤维化分为腹膜纤维化组和无腹膜纤维化组,查阅患者临床病历资料,检测各组腹膜冲洗液中MMPs/TIMPs、25(OH)D_(3)水平,分析影响PD患者PDAP或腹膜纤维化发生的易感因素,采用受试者工作特征(ROC)曲线分析腹膜冲洗液MMPs/TIMPs、25(OH)D_(3)水平变化对PDAP或腹膜纤维化发生的预测价值。结果58例PD中13例(22.41%)出现PDAP,10例(17.24%)出现腹膜纤维化。多因素Logistic回归分析显示,年龄、透析时间、MMPs/TIMPs、25(OH)D_(3)是PD患者PDAP发生的影响因素(P<0.05,P<0.01);透析时间、MMPs/TIMPs、25(OH)D_(3)是PD患者腹膜纤维化发生的影响因素(P<0.05,P<0.01)。ROC曲线分析显示,腹膜冲洗液MMPs/TIMPs、25(OH)D_(3)联合检测预测PD患者PDAP、腹膜纤维化发生的曲线下面积、敏感度分别为0.840、0.835和0.892、0.811,均较二者单一检测高。结论PD患者发生PDAP、腹膜纤维化的风险不容忽视,加强对年龄≥60岁、PD时间较长高危人群的重视,通过监测腹膜冲洗液MMPs/TIMPs、25(OH)D_(3)水平,对PD患者PDAP、腹膜纤维化的有效防治十分重要。 展开更多
关键词 腹膜透析 腹膜透析相关性腹膜炎 腹膜纤维化 基质金属蛋白酶/金属蛋白酶组织抑制因子 25-羟基维生素D 3 影响因素分析
下载PDF
Atorvastatin reduces myocardial fibrosis in a rat model with post- myocardial infarction heart failure by increasing the matrix metaHoproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio 被引量:17
11
作者 AN Zhe YANG Guang +4 位作者 HE Yu-quan DONG Ning GE Li-li LI Shu-mei ZHANG Wen-qi 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第11期2149-2156,共8页
Background The cholesterol-lowering statin drugs have some non-lipid-lowering effects, such as inhibiting myocardial remodeling. However, the underlying mechanism is still unclear. Methods The left anterior descending... Background The cholesterol-lowering statin drugs have some non-lipid-lowering effects, such as inhibiting myocardial remodeling. However, the underlying mechanism is still unclear. Methods The left anterior descending coronary artery was ligated to establish a rat model of heart failure, and the rats were divided into a sham operation (SO) group, myocardial infarction model (MI) group, and MI-atorvastatin group. Changes in hemodynamic parameters were recorded after the final drug administration. Histological diagnosis was made by reviewing hematoxylin and eosin (HE) stained tissue. Real-time quantitative polymerase chain reaction (PCR) was performed to determine the expressions of type I and type III collagen, matrix metalloproteinase-2 (MMP-2), and tissue matrix metalloproteinase inhibitor-2 (TIMP-2). Further, primary rat cardiac fibroblasts were cultured and the MTT assay was performed to determine the effect of atorvastatin on cardiac fibroblast proliferation. Results The model of heart failure was established and the results of HE staining and Masson's trichrome staining revealed that the rats in the heart failure group showed obvious hyperplasia of fibrotic tissue, which was significantly reduced in the atorvastatin group. Real-time quantitative PCR showed that the MI group showed a significantly increased expression of type I and type III coltagen, MMP-2, and TIMP-2, but a significantly reduced MMP-2/T'IMP- 2 ratio. Compared with the MI group, the atorvastatin group showed significantly reduced expression of type I and III collagen, unchanged expression of MMP-2, significantly reduced expression of TIMP-2, and an increased MMP-2/ TIMP-2 ratio. We further found that atorvastatin significantly inhibited the Ang II-induced fibroblast proliferation and the expression of type I and type III collagen in cardiac fibroblasts while increasing the MMP-2/TIMP-2 ratio. Conclusions These data suggest that atorvastatin can inhibit cardiac fibroblast proliferation and enhance collagen degradation by increasing the MMP-2/TIMP-2 ratio, thereby inhibiting the formation of myocardial fibrosis in rats with heart failure after myocardial infarction. 展开更多
关键词 ATORVASTATIN cardiac fibroblasts matrix metalloproteinase-2 tissue matrix metalloproteinase inhibitor-2
原文传递
Effects of Saikosaponin-D on syndecan-2,matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in rats with hepatocellular carcinoma 被引量:13
12
作者 Xiaoli Jia Shuangsuo Dang +4 位作者 Yanan Cheng Xin Zhang Mei Li Yaping Li Siyuan Li 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2012年第3期415-422,共8页
OBJECTIVE:To investigate effects of Saikosaponin D(SSd) on syndecan-2,matrix metalloproteinases(MMPs) and tissue inhibitor of metalloproteinases-2(TIMP-2) in livers of rat with hepatocellular carcinoma(HCC).METHODS:Ma... OBJECTIVE:To investigate effects of Saikosaponin D(SSd) on syndecan-2,matrix metalloproteinases(MMPs) and tissue inhibitor of metalloproteinases-2(TIMP-2) in livers of rat with hepatocellular carcinoma(HCC).METHODS:Male SD rats were divided into control(n=10),model(n=20) and SSd(n=20) groups,and model and SSd groups given intragastric 0.2%(w/v) N-diethylnitrosamine to induce HCC.SSd group received 0.03%(w/v) SSd in saline.Liver samples were analysed immunohistochemically for syndecan-2,MMP-2,MMP-13 and TIMP-2 at 16 weeks.RESULTS:The model group had more malignant nodules than the SSd group;all model-group HCC cells were grade III;SSd-group HCC cells were grades I-II.Controls showed normal hepatic cell phenotypes and no syndecan-2 + staining.Syndecan-2 + staining was greater in the model group(35.2%,P≤0.001) than in controls or the SSd group(16.5%,P ≤ 0.001).The model group had more intense MMP-2 + staining than controls(0.37 vs 0.27,P≤0.01) or the SSd group(0.31 vs 0.37,P≤0.05);and higher MMP-13 + staining(72.55%) than in controls(12.55%,P≤0.001) and SSd group(20.18%,P≤0.01).The model group also had more TIMP-2 + staining(57.2%) than controls(20.9%,P≤0.001) and SSd group(22.7%,P≤0.001).Controls and SSd group showed no difference in TIMP-2 + rates.CONCLUSION:SSd inhibited HCC development,and downregulated expression of syndecan-2,MMP-2,MMP-13 and TIMP-2 in rat HCC liver tissue. 展开更多
关键词 Carcinoma Hepatocellular SAIKOSAPONIN Syndecan-2 matrix metalloproteinases tissue inhibitor of metalloproteinase inhibitor-2
原文传递
Effects of (-)-epigallocatechin-3-gallate on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in fibroblasts irradiated with ultraviolet A 被引量:8
13
作者 宋秀祖 夏济平 毕志刚 《Chinese Medical Journal》 SCIE CAS CSCD 2004年第12期1838-1841,共4页
Background It is known that ultraviolet irradiation can affect cellular function through a number of signaling pathways ( ) epigallocatechin 3 gallate (EGCG) is the major effective component in green tea and can offer... Background It is known that ultraviolet irradiation can affect cellular function through a number of signaling pathways ( ) epigallocatechin 3 gallate (EGCG) is the major effective component in green tea and can offer protection from ultraviolet induced damage In this study, we investigated the protective mechanism of EGCG on human dermal fibroblasts damaged by ultraviolet A (UVA) in vitro Methods Transcription factor Jun protein levels were measured by Western blot Matrix metalloproteinase 1 (MMP 1) and tissue inhibitor of metalloproteinase 1 (TIMP 1) mRNA were studied by reverse transcription polymerase chain reaction (RT PCR) analysis in conjunction with computer assisted image analysis MMP 1 and TIMP 1 proteins were quantified by enzyme linked immunosorbent assay (ELISA) Results EGCG decreased transcription activity of Jun protein after induction by UVA Both the mRNA and protein levels of MMP 1 were increased by UVA irradiation, while no significant changes were observed in TIMP 1 levels The ratio of MMP 1 to TIMP 1 showed statistically significant differences compared with the control EGCG decreased the ratio of MMP 1 to TIMP 1 by inhibiting UVA induced MMP 1 expression ( P <0 05) Conclusion EGCG can protect human fibroblasts against UVA damage by downregulating the transcription activity of Jun protein and the expression of MMP 1 The ratio of MMP 1 to TIMP 1, rather than the levels of MMP 1 or TIMP 1 alone, may play a significant role in human skin photodamage 展开更多
关键词 ultraviolet A · fibroblasts · (-)-epigallocatechin-3-gallate · matrix metalloproteinase 1 · tissue inhibitor of metalloproteinase-1
原文传递
MMP-7、MMP-9及其抑制剂TIMP-3在骨性关节炎患者膝关节滑膜中的表达和意义 被引量:14
14
作者 吕大鹏 白伦浩 +2 位作者 孔冉冉 李毓卓 王勇 《中国医科大学学报》 CAS CSCD 北大核心 2009年第4期284-285,共2页
目的探讨基质金属蛋白酶(MMP-7、MMP-9)及金属蛋白酶组织抑制物(TIMP-3)在骨性关节炎患者膝关节滑膜中的表达和意义。方法对40例膝关节滑膜标本应用SABC免疫组化法显色MMP-7、MMP-9及TIMP-3在病变组和正常组的表达,并用HE染色观察细胞... 目的探讨基质金属蛋白酶(MMP-7、MMP-9)及金属蛋白酶组织抑制物(TIMP-3)在骨性关节炎患者膝关节滑膜中的表达和意义。方法对40例膝关节滑膜标本应用SABC免疫组化法显色MMP-7、MMP-9及TIMP-3在病变组和正常组的表达,并用HE染色观察细胞形态。结果MMP-7、MMP-9及TIMP-3的表达在正常关节滑膜与重度骨性关节炎患者膝关节滑膜中的表达有显著差异(P<0.05)。结论MMP-7、MMP-9及TIMP-3的表达是骨性关节炎重要的标志性诊断指标。 展开更多
关键词 基质金属蛋白酶7 基质金属蛋白酶9 金属蛋白酶组织抑制物3 骨性关节炎
下载PDF
葛根素对糖尿病大鼠肾功能及肾组织MMP-3、TIMP-1表达的影响 被引量:15
15
作者 刘淑霞 段惠军 +4 位作者 张玉军 陈志强 何宁 刘青娟 李英敏 《天然产物研究与开发》 CAS CSCD 2003年第6期531-535,共5页
目的 探讨葛根素对糖尿病大鼠肾小球结构、功能及肾组织基质金属蛋白酶 3(MMP 3)、组织抑制剂 1(TIMP 1)表达的影响。方法 腹腔注射链脲佐菌素诱发大鼠糖尿病模型 ,每日ip葛根素注射液 ,共 16周。采用原位杂交法检测肾小球TIMP 1mRNA... 目的 探讨葛根素对糖尿病大鼠肾小球结构、功能及肾组织基质金属蛋白酶 3(MMP 3)、组织抑制剂 1(TIMP 1)表达的影响。方法 腹腔注射链脲佐菌素诱发大鼠糖尿病模型 ,每日ip葛根素注射液 ,共 16周。采用原位杂交法检测肾小球TIMP 1mRNA表达 ,流式细胞术和免疫组化检测肾皮质MMP 3、TIMP 1及Ⅳ型胶原、层粘连蛋白表达。结果 糖尿病组较对照组肾小球TIMP 1mRNA及蛋白表达增加 ,MMP 3、TIMP 1及Ⅳ型胶原、层粘连蛋白表达亦增加 ;葛根素用药组较糖尿病组TIMP 1mRNA、蛋白及MMP 3、Ⅳ型胶原、层粘连蛋白表达减少。结论 葛根素对糖尿病大鼠肾功能、形态的影响具有保护作用 ,除降低血糖外 ,调节肾小球MMP 3、TIMP 1表达式从而减轻肾小球细胞外基质沉积也可能是其作用途径之一。 展开更多
关键词 葛根素 大鼠 糖尿病肾病 基质金属蛋白酶-3 治疗
下载PDF
膝骨关节炎患者血清MMP-3、TIMP-1水平变化及相关性研究 被引量:41
16
作者 张金山 程园园 刘健 《安徽医科大学学报》 CAS 北大核心 2012年第9期1066-1069,共4页
目的观察膝骨关节炎(KOA)患者血清基质金属蛋白酶-3(MMP-3)、基质金属蛋白酶组织抑制物-1(TIMP-1)变化并进行相关性研究。方法采用酶联免疫吸附法(ELISA)对60例KOA患者(KOA组)及30例正常对照组血清MMP-3、TIMP-1、白细胞介素-1β(IL-1β... 目的观察膝骨关节炎(KOA)患者血清基质金属蛋白酶-3(MMP-3)、基质金属蛋白酶组织抑制物-1(TIMP-1)变化并进行相关性研究。方法采用酶联免疫吸附法(ELISA)对60例KOA患者(KOA组)及30例正常对照组血清MMP-3、TIMP-1、白细胞介素-1β(IL-1β)、转化生长因子-β(TGF-β)进行检测;采用流式细胞术检测外周血CD4+CD25+CD127low/-调节性T细胞(Treg)比例;依据KOA严重程度指数(LequesneMG)评分标准将60例KOA患者分为轻、中、重3组,并以60岁为界限将KOA患者分为<60岁组(26例)、≥60岁组(34例),分析KOA患者血清MMP-3、TIMP-1变化及与LequesneMG积分、症状量化积分、国际普适生活质量量表(SF-36)积分、焦虑自评量表(SAS)积分、抑郁自评量表(SDS)积分、红细胞沉降率(ESR)、超敏C-反应蛋白(hs-CRP)、IL-1β、TGF-β、CD4+CD25+CD127low/-Treg的相关性。结果①与正常对照组比较,KOA组血清MMP-3水平显著升高,TIMP-1水平显著降低(P<0.05)。②重度组血清MMP-3、TIMP-1水平显著高于轻度组及中度组,中度组显著高于轻度组(P<0.05)。③与<60岁组比较,≥60岁组血清MMP-3、TIMP-1显著升高(P<0.05)。④相关性分析显示KOA患者血清MMP-3、TIMP-1与LequesneMG积分、SAS积分、ESR、hs-CRP、IL-1β、TGF-β呈正相关,与SF-36各维度积分呈负相关,MMP-3与CD4+CD25+CD127low/-Treg呈负相关(P<0.05)。结论 KOA患者血清MMP-3显著升高,TIMP-1显著降低,其表达失调可能参与KOA发病过程。 展开更多
关键词 膝骨关节炎 基质金属蛋白酶-3 基质金属蛋白酶 组织抑制物-1
下载PDF
不同干预因素对膝骨关节炎患者滑液中MMP-3和TIMP-1的影响 被引量:15
17
作者 徐海涛 陈游 +3 位作者 陈立科 李菊元 张薇 吴波 《中南大学学报(医学版)》 CAS CSCD 北大核心 2008年第1期47-52,共6页
目的:观察透明质酸钠(hyaluronic acid,HA)、硫酸氨基葡萄糖(glucosamine sulfate,GS)、关节镜下关节清理术(arthroscopic debridment,AD)治疗膝骨关节炎(osteoarthritis,OA)时,对关节液内基质金属蛋白酶-3(matrix metalloproteinase-3,... 目的:观察透明质酸钠(hyaluronic acid,HA)、硫酸氨基葡萄糖(glucosamine sulfate,GS)、关节镜下关节清理术(arthroscopic debridment,AD)治疗膝骨关节炎(osteoarthritis,OA)时,对关节液内基质金属蛋白酶-3(matrix metalloproteinase-3,MMP-3)、组织型金属蛋白酶抑制剂-1(tissue inhibitor of metallo-proteinase-1,TIMP-1)水平的影响,并探讨其治疗OA的机制。方法:60例膝OA病人(64关节)分为HA组和GS+HA组,并于HA组和GS+HA组选取部分病例组成HA′组和GS+HA′组,再与AD组比较。于治疗前和治疗后4周、6月抽取关节液样本,采用双抗体夹心ELISA法测定关节液内MMP-3和TIMP-1水平。结果:HA组和GS+HA组治疗4周时关节液中MMP-3水平及MMP-3/TIMP-1比值均较治疗前降低(P<0.01),且在治疗半年后MMP-3水平和MMP-3/TIMP-1比值下降仍有统计学意义(P<0.01)。GS+HA组治疗4周时TIMP-1水平较治疗前显著升高(P<0.01);HA组治疗4周时TIMP-1水平虽较治疗前升高,但无统计学意义(P>0.05)。AD组治疗4周与治疗前比较,关节液中MMP-3水平降低(P<0.01),TIMP-1水平升高(P<0.01),MMP-3/TIMP-1比值降低(P<0.01);且在治疗半年后MMP-3水平、MMP-3/TIMP-1比值下降仍有统计学意义(P<0.01);但治疗6月后与治疗4周比较,TIMP-1水平降低(P<0.01),MMP-3/TIMP-1比值升高(P<0.01)。HA组与GS+HA组比较,GS+HA组治疗4周时TIMP-1升高水平显著高于HA组(P<0.01)。AD组与相应的HA′组、GS+HA′组比较,治疗4周时AD组的TIMP-1升高最明显(P<0.01),其余指标无明显差异。结论:⑴HA,GS和AD治疗均能使膝关节OA患者关节液内的MMP-3水平、MMP-3/TIMP-1比值降低。⑵HA对关节液内的TIMP-1水平无明显影响,但同时应用GS可使关节液内的TIMP-1水平升高。HA和GS可通过不同的机制发挥治疗OA的作用。HA联合GS治疗可能获得更好的疗效。⑶在中、重度膝关节OA患者中,与相应的HA′组、GS+HA′组比较,治疗4周后AD组TIMP-1升高最明显,AD可能获得更好的疗效。⑷对MMP-3和TIMP-1的影响,可能是HA,GS和AD改善OA病情的重要机制。 展开更多
关键词 膝关节 骨关节炎 基质金属蛋白酶-3 组织型基质金属蛋白酶抑制剂-1
下载PDF
基质金属蛋白酶-3在强直性脊柱炎中的作用和意义探讨 被引量:14
18
作者 古洁若 张汉伟 +3 位作者 赵丽珂 黄烽 颜光美 余得恩 《中国药物与临床》 CAS 2004年第4期270-276,共7页
目的通过比较强直性脊柱炎(AS)病人抗肿瘤坏死因子(TNF)-α单克隆抗体药物(remicade)治疗前后的膝关节滑膜细胞的基因谱变化,找出缓解AS病情相关的主要基质金属蛋白酶(MMP)-3,并探讨MMP-3潜在调控的作用和在AS发病中的作用机制和意义。... 目的通过比较强直性脊柱炎(AS)病人抗肿瘤坏死因子(TNF)-α单克隆抗体药物(remicade)治疗前后的膝关节滑膜细胞的基因谱变化,找出缓解AS病情相关的主要基质金属蛋白酶(MMP)-3,并探讨MMP-3潜在调控的作用和在AS发病中的作用机制和意义。方法从AS病人在remicade治疗前和治疗3个月后的关节滑膜细胞的基因表达谱(用含1176基因的cDNA微阵列检测)结果中筛选的靶基因即差异表达最显著的MMP-3为特异性刺激因子,用反转录-聚合酶链反应(RT-PCR)方法检测它诱导健康志愿者外周血单个核细胞(PBMC)的炎症相关基因TNF-α、c-jun和c-fos的表达。结果比较AS病人治疗前后的关节滑膜细胞基因差异表达的结果,MMP-3治疗后下调最显著(P=0.0147)。与MMP-3聚类在一起的基因有111个,和MMP-3相关性最强的基因是金属蛋白酶抑制剂前体(TIMP)-1;MMP-3能显著诱导PBMC的TNF-α、c-jun和c-fos的表达。结论在remicade治疗AS过程中,下调MMP-3是最重要的环节之一;通过检测MMP-3在关节滑膜细胞组织中的表达水平可作为AS诊断和病情进展监控的参考指标;MMP-3下调,可能使TNF-TNFR2-JNK-AP-1信息通道的激活状态减弱,从而减少致炎因子的释放,调整异常的基质降解和血管形成等病理因素,缓解AS炎症、减少软骨和骨质破坏的作用。 展开更多
关键词 强直性脊柱炎 基质金属蛋白酶-3 REMICADE 反转录-聚合酶链反应 MMP-3 关节滑膜细胞 外周血单个核细胞 金属蛋白酶抑制剂 单克隆抗体药物 (TNF)-Α 抗肿瘤坏死因子 TNF-α c-fos c-jun 基因差异表达 治疗前后 基因表达谱
下载PDF
基质金属蛋白酶1、3,基质金属蛋白酶组织抑制剂1和miR-29在大鼠肺纤维化中及活性维生素D3处理后的表达与作用 被引量:10
19
作者 许梦婷 刘乃国 +2 位作者 刘营 龚悦 李新静 《解剖学杂志》 CSCD 北大核心 2017年第3期266-270,285,F0002,共7页
目的:探讨大鼠肺纤维化发生发展中基质金属蛋白酶1(MMP1)、MMP3、基质金属蛋白酶组织抑制剂1(TIMP1)及miR-29的表达和作用以及活性维生素D3[1,25(OH)_2D_3]处理对这些基因表达的影响。方法:雄性SD大鼠随机分为预防组和治疗组。预防组分... 目的:探讨大鼠肺纤维化发生发展中基质金属蛋白酶1(MMP1)、MMP3、基质金属蛋白酶组织抑制剂1(TIMP1)及miR-29的表达和作用以及活性维生素D3[1,25(OH)_2D_3]处理对这些基因表达的影响。方法:雄性SD大鼠随机分为预防组和治疗组。预防组分为对照组Ⅰ、模型组Ⅰ和给药组Ⅰ,治疗组分为对照组Ⅱ、模型组Ⅱ和给药组Ⅱ。模型组Ⅰ/Ⅱ和给药组Ⅰ/Ⅱ经气管注入博莱霉素,对照组Ⅰ/Ⅱ经气管注入生理盐水。预防组和治疗组分别于术后第2和14天腹腔注射给药,给药组给予活性维生素D3,模型组给予活性维生素D3溶剂,对照组给予生理盐水。预防组的各组分别于术后第14、21、28天处死大鼠取材,治疗组的各组分别于术后第21和28天处死大鼠取材。实时定量PCR检测大鼠肺组织中miR-29a及TIMP1 mRNA表达水平,免疫组织化学检测组织中MMP1、MMP3和TIMP1的表达水平。结果:模型组Ⅰ/Ⅱ和给药组Ⅰ/Ⅱ中的MMP1、MMP3和TIMP1的表达均明显高于相同时间点对照组Ⅰ/Ⅱ中的表达,而miR-29a的表达明显低于相应的对照组Ⅰ/Ⅱ;给药组Ⅰ/Ⅱ中MMP1、MMP3和TIMP1的表达均低于相应时间点的模型组Ⅰ/Ⅱ的表达,而给药组Ⅰ/Ⅱ中miR-29a的表达则高于模型组Ⅰ/Ⅱ中的表达。结论:MMP1、MMP3、TIMP1和miR-29在大鼠肺纤维化发生发展中具有重要作用,活性维生素D3可以促进miR-29表达,抑制MMP1、MMP3、TIMP1的表达;可能是通过miR-29调节包括MMP1、MMP3、TIMP1在内的多种靶基因来发挥抑制纤维化的作用。 展开更多
关键词 肺纤维化 活性维生素D3 MIR-29 基质金属蛋白酶1 基质金属蛋白酶3 基质金属蛋白酶组织抑制剂1 大鼠
下载PDF
丹参单体IH764-3通过下调H_2O_2刺激的肝星状细胞FAK水平影响MMP-13和TIMP-1的表达 被引量:10
20
作者 刘丽 姜慧卿 +1 位作者 张晓岚 赵冬强 《中国应用生理学杂志》 CAS CSCD 北大核心 2007年第4期482-486,I0013,共6页
目的:研究丹参单体IH764-3对H2O2刺激的肝星状细胞(HSC)基质金属蛋白酶-13(MMP-13)、基质金属蛋白酶组织抑制因子-1(TIMP-1)表达的影响以及此过程中粘着斑激酶(FAK)的变化。方法:应用RT-PCR方法检测MMP-13及FAK mRNA表达,原位杂交方法检... 目的:研究丹参单体IH764-3对H2O2刺激的肝星状细胞(HSC)基质金属蛋白酶-13(MMP-13)、基质金属蛋白酶组织抑制因子-1(TIMP-1)表达的影响以及此过程中粘着斑激酶(FAK)的变化。方法:应用RT-PCR方法检测MMP-13及FAK mRNA表达,原位杂交方法检测TIMP-1mRNA水平,Western blotting技术检测FAK及TIMP-1蛋白表达。结果:IH764-3干预组的MMP-13mRNA在2h的表达强度明显上调,而TIMP-1mRNA表达明显受抑,FAK mRNA表达强度明显下调;IH764-3干预24h组FAK及TIMP-1蛋白表达受抑制。结论:丹参单体IH764-3可以诱导MMP-13表达,抑制TIMP-1表达,下调FAK表达是其中的机制之一。 展开更多
关键词 丹参单体IH764—3 肝星状细胞 基质金属蛋白酶-13 粘着斑激酶 基质金属蛋白酶组织抑制因子-1
下载PDF
上一页 1 2 10 下一页 到第
使用帮助 返回顶部